Glenn M Chertow (G M Chertow)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 96

Top Topics

Chronic Kidney Disease

Glycemic Control

Cardiovascular Events

Top Venues

Clinical journal of the American Society of Nephrology : CJASN

Journal of the American Society of Nephrology : JASN

Nature medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Jinnie J Rhee, Jialin Han, Maria E Montez-Rath, Glenn M Chertow
Comparative effectiveness of sodium-glucose cotransporter-2 inhibitors versus glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes and mild/moderate chronic kidney disease. Diabetes, obesity & metabolism (2024)
Jinnie J Rhee, Jialin Han, Maria E Montez-Rath, Glenn M Chertow
Comparative effectiveness of sodium-glucose cotransporter-2 inhibitors versus glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes and mild/moderate chronic kidney disease. Diabetes, obesity & metabolism 26 (4) (2024)
Robert A Fletcher, William G Herrington, Rajiv Agarwal, Kaitlin J Mayne, Clare Arnott, Meg J Jardine, Kenneth W Mahaffey, Vlado Perkovic, Natalie Staplin, David Collins Wheeler, Glenn M Chertow, Hiddo J Lambers Heerspink, Brendon L Neuen
Effects of SGLT2 inhibitors on cause-specific cardiovascular death in patients with chronic kidney disease: a meta-analysis of CKD progression trials. Clinical journal of the American Society of Nephrology : CJASN (2024)
Enass El-Sayed, Youssef M K Farag, Katherine Scovner Ravi, Glenn M Chertow, Finnian R Mc Causland
Association of Changes in Vector Length with Changes in Left Ventricular Mass among Patients on Maintenance Hemodialysis: A Secondary Analysis of the Frequent Hemodialysis Network Daily Trial. Kidney360 5 (6) (2024)
Enass El-Sayed, Youssef M K Farag, Katherine Scovner Ravi, Glenn M Chertow, Finnian R Mc Causland
Association of Changes in Vector Length with Changes in Left Ventricular Mass Among Patients on Maintenance Hemodialysis: A Secondary Analysis of the Frequent Hemodialysis Network Daily Trial. Kidney360 (2024)
Shweta Bansal, Robert Boucher, Jincheng Shen, Guo Wei, Glenn M Chertow, Paul K Whelton, William C Cushman, Alfred K Cheung, Srinivasan Beddhu, null null
Role of Diuretics in Cardiovascular Events and Mortality in Systolic Blood Pressure Intervention Trial: A Post Hoc Analysis. Clinical journal of the American Society of Nephrology : CJASN 19 (5) (2024)
Nicholas M Pajewski, Srinivasan Beddhu, Adam P Bress, Tara I-Hsin Chang, Glenn M Chertow, Alfred K Cheung, William C Cushman, Barry I Freedman, Tom Greene, Karen C Johnson, Byron C Jaeger, Manjula Kurella Tamura, Cora Elizabeth Lewis, Mahboob Rahman, David M Reboussin, Michael V Rocco, Jeff D Williamson, Paul K Whelton, Jackson T Wright, Paul E Drawz, Joachim H Ix
The Legacy Effect of Intensive versus Standard Blood Pressure Control on the Incidence of Dialysis or Kidney Transplantation. Journal of the American Society of Nephrology : JASN (2024)
Shweta Bansal, Robert Boucher, Jincheng Shen, Guo Wei, Glenn M Chertow, Paul K Whelton, William C Cushman, Alfred K Cheung, Srinivasan Beddhu, null null
Role of Diuretics in Cardiovascular Events and Mortality in Systolic Blood Pressure Intervention Trial: A Post Hoc Analysis. Clinical journal of the American Society of Nephrology : CJASN 19 (5) (2024)
Ian Ellis McCoy, Glenn M Chertow
The Use of Kidney Disease Improving Global Outcomes AKI Definitions in AKI Research: PRO. Kidney360 5 (7) (2024)
Jinnie J Rhee, Jialin Han, Maria E Montez-Rath, Glenn M Chertow
Comparative effectiveness of sodium-glucose cotransporter-2 inhibitors versus glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes and mild/moderate chronic kidney disease. Diabetes, obesity & metabolism 26 (4) (2024)
Anjay Rastogi, Ashté Collins, Ellie Kelepouris, Wayne Kotzker, John P Middleton, Minesh Rajpal, Prabir Roy-Chaudhury, Glenn M Chertow
Practical Considerations and Implementation of Sodium-Glucose Co-Transporter-2 Inhibitors in Chronic Kidney Disease: Who, When, and How? A Position Statement by Nephrologists. Journal of primary care & community health 15 (2024)
Marika M Cusick, Rebecca L Tisdale, Glenn M Chertow, Douglas K Owens, Jeremy D Goldhaber-Fiebert
Population-Wide Screening for Chronic Kidney Disease. Annals of internal medicine 177 (1) (2024)
Anjay Rastogi, Ashté Collins, Ellie Kelepouris, Wayne Kotzker, John P Middleton, Minesh Rajpal, Prabir Roy-Chaudhury, Glenn M Chertow
Practical Considerations and Implementation of Sodium-Glucose Co-Transporter-2 Inhibitors in Chronic Kidney Disease: Who, When, and How? A Position Statement by Nephrologists. Journal of primary care & community health 15 (2024)
Glenn M Chertow, Anna Marie Chang, G Michael Felker, Mark Heise, Elena Velkoska, Bengt Fellström, David M Charytan, Regina Clementi, Charles Michael Gibson, Shaun G Goodman, Meg Jardine, Adeera Levin, Yuliya Lokhnygina, Jenny Mears, Roxana Mehran, Stenvinkel Peter, Angela Yee-Moon Wang, David C Wheeler, Carmine Zoccali, Paul M Ridker, Kenneth W Mahaffey, Pierluigi Tricoci, Myles Wolf
Author Correction: IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial. Nature medicine (2024)
Glenn M Chertow, Anna Marie Chang, G Michael Felker, Mark Heise, Elena Velkoska, Bengt Fellström, David M Charytan, Regina Clementi, Charles Michael Gibson, Shaun G Goodman, Meg Jardine, Adeera Levin, Yuliya Lokhnygina, Jenny Mears, Roxana Mehran, Stenvinkel Peter, Angela Yee-Moon Wang, David C Wheeler, Carmine Zoccali, Paul M Ridker, Kenneth W Mahaffey, Pierluigi Tricoci, Myles Wolf
IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial. Nature medicine 30 (8) (2024)
Glenn M Chertow, Anna Marie Chang, G Michael Felker, Mark Heise, Elena Velkoska, Bengt Fellström, David M Charytan, Regina Clementi, Charles Michael Gibson, Shaun G Goodman, Meg Jardine, Adeera Levin, Yuliya Lokhnygina, Jenny Mears, Roxana Mehran, Stenvinkel Peter, Angela Yee-Moon Wang, David C Wheeler, Carmine Zoccali, Paul M Ridker, Kenneth W Mahaffey, Pierluigi Tricoci, Myles Wolf
IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial. Nature medicine 30 (8) (2024)
Glenn M Chertow, Anna Marie Chang, G Michael Felker, Mark Heise, Elena Velkoska, Bengt Fellström, David M Charytan, Regina Clementi, Charles Michael Gibson, Shaun G Goodman, Meg Jardine, Adeera Levin, Yuliya Lokhnygina, Jenny Mears, Roxana Mehran, Stenvinkel Peter, Angela Yee-Moon Wang, David C Wheeler, Carmine Zoccali, Paul M Ridker, Kenneth W Mahaffey, Pierluigi Tricoci, Myles Wolf
IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial. Nature medicine 30 (8) (2024)
Anjay Rastogi, Ashté Collins, Ellie Kelepouris, Wayne Kotzker, John P Middleton, Minesh Rajpal, Prabir Roy-Chaudhury, Glenn M Chertow
Practical Considerations and Implementation of Sodium-Glucose Co-Transporter-2 Inhibitors in Chronic Kidney Disease: Who, When, and How? A Position Statement by Nephrologists. Journal of primary care & community health 15 (2024)
Enass El-Sayed, Youssef M K Farag, Katherine Scovner Ravi, Glenn M Chertow, Finnian R Mc Causland
Association of Changes in Vector Length with Changes in Left Ventricular Mass among Patients on Maintenance Hemodialysis: A Secondary Analysis of the Frequent Hemodialysis Network Daily Trial. Kidney360 5 (6) (2024)
Nicholas M Pajewski, Srinivasan Beddhu, Adam P Bress, Tara I-Hsin Chang, Glenn M Chertow, Alfred K Cheung, William C Cushman, Barry I Freedman, Tom Greene, Karen C Johnson, Byron C Jaeger, Manjula Kurella Tamura, Cora Elizabeth Lewis, Mahboob Rahman, David M Reboussin, Michael V Rocco, Jeff D Williamson, Paul K Whelton, Jackson T Wright, Paul E Drawz, Joachim H Ix
The Legacy Effect of Intensive versus Standard BP Control on the Incidence of Needing Dialysis or Kidney Transplantation. Journal of the American Society of Nephrology : JASN (2024)
Glenn M Chertow, Anna Marie Chang, G Michael Felker, Mark Heise, Elena Velkoska, Bengt Fellström, David M Charytan, Regina Clementi, Charles Michael Gibson, Shaun G Goodman, Meg Jardine, Adeera Levin, Yuliya Lokhnygina, Jenny Mears, Roxana Mehran, Stenvinkel Peter, Angela Yee-Moon Wang, David C Wheeler, Carmine Zoccali, Paul M Ridker, Kenneth W Mahaffey, Pierluigi Tricoci, Myles Wolf
IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial. Nature medicine (2024)
Jinnie J Rhee, Jialin Han, Maria E Montez-Rath, Glenn M Chertow
Comparative effectiveness of sodium-glucose cotransporter-2 inhibitors versus glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes and mild/moderate chronic kidney disease. Diabetes, obesity & metabolism 26 (4) (2024)
Anjay Rastogi, Ashté Collins, Ellie Kelepouris, Wayne Kotzker, John P Middleton, Minesh Rajpal, Prabir Roy-Chaudhury, Glenn M Chertow
Practical Considerations and Implementation of Sodium-Glucose Co-Transporter-2 Inhibitors in Chronic Kidney Disease: Who, When, and How? A Position Statement by Nephrologists. Journal of primary care & community health 15 (2024)
Robert A Fletcher, William G Herrington, Rajiv Agarwal, Kaitlin J Mayne, Clare Arnott, Meg J Jardine, Kenneth W Mahaffey, Vlado Perkovic, Natalie Staplin, David Collins Wheeler, Glenn M Chertow, Hiddo J Lambers Heerspink, Brendon L Neuen
Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Cause-Specific Cardiovascular Death in Patients with CKD: A Meta-Analysis of CKD Progression Trials. Clinical journal of the American Society of Nephrology : CJASN (2024)
Arnold Silva, Susan Edelstein, Yang Yang, David P Rosenbaum, Lori Battelli, Glenn M Chertow
Tenapanor improves long-term control of high phosphate concentrations in the blood in patients receiving maintenance dialysis: a plain language summary of the NORMALIZE study. Current medical research and opinion 40 (8) (2024)
Marika M Cusick, Rebecca L Tisdale, Glenn M Chertow, Douglas K Owens, Jeremy D Goldhaber-Fiebert
Population-Wide Screening for Chronic Kidney Disease. Annals of internal medicine 177 (1) (2024)
Ian Ellis McCoy, Glenn M Chertow
The Use of KDIGO AKI Definitions in AKI Research: PRO. Kidney360 (2024)
Marika M Cusick, Rebecca L Tisdale, Glenn M Chertow, Douglas K Owens, Jeremy D Goldhaber-Fiebert
Population-Wide Screening for Chronic Kidney Disease. Annals of internal medicine 177 (1) (2024)
Ian Ellis McCoy, Glenn M Chertow
The Use of Kidney Disease Improving Global Outcomes AKI Definitions in AKI Research: PRO. Kidney360 5 (7) (2024)
Glenn M Chertow, Anna Marie Chang, G Michael Felker, Mark Heise, Elena Velkoska, Bengt Fellström, David M Charytan, Regina Clementi, Charles Michael Gibson, Shaun G Goodman, Meg Jardine, Adeera Levin, Yuliya Lokhnygina, Jenny Mears, Roxana Mehran, Stenvinkel Peter, Angela Yee-Moon Wang, David C Wheeler, Carmine Zoccali, Paul M Ridker, Kenneth W Mahaffey, Pierluigi Tricoci, Myles Wolf
Author Correction: IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial. Nature medicine (2024)
Glenn M Chertow, Anna Marie Chang, G Michael Felker, Mark Heise, Elena Velkoska, Bengt Fellström, David M Charytan, Regina Clementi, Charles Michael Gibson, Shaun G Goodman, Meg Jardine, Adeera Levin, Yuliya Lokhnygina, Jenny Mears, Roxana Mehran, Stenvinkel Peter, Angela Yee-Moon Wang, David C Wheeler, Carmine Zoccali, Paul M Ridker, Kenneth W Mahaffey, Pierluigi Tricoci, Myles Wolf
IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial. Nature medicine (2024)
Shweta Bansal, Robert Boucher, Jincheng Shen, Guo Wei, Glenn M Chertow, Paul K Whelton, William C Cushman, Alfred K Cheung, Srinivasan Beddhu, null null
Role of Diuretics in Cardiovascular Events and Mortality in Systolic Blood Pressure Intervention Trial: A Post Hoc Analysis. Clinical journal of the American Society of Nephrology : CJASN 19 (5) (2024)
Shweta Bansal, Robert Boucher, Jincheng Shen, Guo Wei, Glenn M Chertow, Paul K Whelton, William C Cushman, Alfred K Cheung, Srinivasan Beddhu, null null
Role of Diuretics in Cardiovascular Events and Mortality in Systolic Blood Pressure Intervention Trial: A Post Hoc Analysis. Clinical journal of the American Society of Nephrology : CJASN (2024)
Shweta Bansal, Robert Boucher, Jincheng Shen, Guo Wei, Glenn M Chertow, Paul K Whelton, William C Cushman, Alfred K Cheung, Srinivasan Beddhu, null null
Role of Diuretics in Cardiovascular Events and Mortality in Systolic Blood Pressure Intervention Trial: A Post Hoc Analysis. Clinical journal of the American Society of Nephrology : CJASN (2024)
Jianling Tao, Osamu Winget Yasui, Neil S Kamdar, Sijie Zheng, Rita A Popat, David H Rehkopf, Glenn M Chertow
Plasmapheresis in ANCA-Associated Vasculitis with Active Kidney Involvement in the United States (2016-2020): A Cross-Sectional Study. Kidney360 (2024)
Ian Ellis McCoy, Glenn M Chertow
The Use of Kidney Disease Improving Global Outcomes AKI Definitions in AKI Research: PRO. Kidney360 5 (7) (2024)
Hiddo J Lambers Heerspink, Vlado Perkovic, Katherine R Tuttle, Pablo E Pergola, Kenneth W Mahaffey, Uptal D Patel, Julie H Ishida, Albert Kuo, Fang Chen, Robert Kustra, Vladimir Petrovic, Ellen Burgess, Naoki Kashihara, Glenn M Chertow
Selonsertib in Patients with Diabetic Kidney Disease: A Phase 2b Randomized Active Run-In Clinical Trial. Journal of the American Society of Nephrology : JASN (2024)
Despina Rüssmann, Prabir Roy-Chaudhury, Glenn M Chertow, Patrick O Gee, Cynthia Chauhan, Steven Macari, Michael Murphy, Patrick Rossignol
Where Are Patients' Voices in Chronic Kidney Disease? Clinical journal of the American Society of Nephrology : CJASN (2024)
Abiy Agiro, Erin Cook, Fan Mu, Alexandra Greatsinger, Jingyi Chen, Angela Zhao, Elaine Louden, Ellen Colman, Pooja Desai, Glenn M Chertow
Hyperkalemia and risk of chronic kidney disease progression: A propensity score matched analysis. Kidney360 (2024)
Enass El-Sayed, Youssef M K Farag, Katherine Scovner Ravi, Glenn M Chertow, Finnian R Mc Causland
Association of Changes in Vector Length with Changes in Left Ventricular Mass among Patients on Maintenance Hemodialysis: A Secondary Analysis of the Frequent Hemodialysis Network Daily Trial. Kidney360 5 (6) (2024)
Jinnie J Rhee, Jialin Han, Maria E Montez-Rath, Glenn M Chertow
Comparative effectiveness of sodium-glucose cotransporter-2 inhibitors versus glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes and mild/moderate chronic kidney disease. Diabetes, obesity & metabolism 26 (4) (2024)
Jinnie J Rhee, Jialin Han, Maria E Montez-Rath, Glenn M Chertow
Comparative effectiveness of sodium-glucose cotransporter-2 inhibitors versus glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes and mild/moderate chronic kidney disease. Diabetes, obesity & metabolism 26 (4) (2024)
Glenn M Chertow, Anna Marie Chang, G Michael Felker, Mark Heise, Elena Velkoska, Bengt Fellström, David M Charytan, Regina Clementi, Charles Michael Gibson, Shaun G Goodman, Meg Jardine, Adeera Levin, Yuliya Lokhnygina, Jenny Mears, Roxana Mehran, Stenvinkel Peter, Angela Yee-Moon Wang, David C Wheeler, Carmine Zoccali, Paul M Ridker, Kenneth W Mahaffey, Pierluigi Tricoci, Myles Wolf
IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial. Nature medicine (2024)
Shweta Bansal, Robert Boucher, Jincheng Shen, Guo Wei, Glenn M Chertow, Paul K Whelton, William C Cushman, Alfred K Cheung, Srinivasan Beddhu, null null
Role of Diuretics in Cardiovascular Events and Mortality in Systolic Blood Pressure Intervention Trial: A Post Hoc Analysis. Clinical journal of the American Society of Nephrology : CJASN 19 (5) (2024)
Abiy Agiro, Erin Cook, Fan Mu, Alexandra Greatsinger, Jingyi Chen, Angela Zhao, Elaine Louden, Ellen Colman, Pooja Desai, Glenn M Chertow
Hyperkalemia and risk of chronic kidney disease progression: A propensity score matched analysis. Kidney360 (2024)
Shweta Bansal, Robert Boucher, Jincheng Shen, Guo Wei, Glenn M Chertow, Paul K Whelton, William C Cushman, Alfred K Cheung, Srinivasan Beddhu, null null
Role of Diuretics in Cardiovascular Events and Mortality in Systolic Blood Pressure Intervention Trial: A Post Hoc Analysis. Clinical journal of the American Society of Nephrology : CJASN (2024)
Enass El-Sayed, Youssef M K Farag, Katherine Scovner Ravi, Glenn M Chertow, Finnian R Mc Causland
Association of Changes in Vector Length with Changes in Left Ventricular Mass among Patients on Maintenance Hemodialysis: A Secondary Analysis of the Frequent Hemodialysis Network Daily Trial. Kidney360 5 (6) (2024)
Arnold Silva, Susan Edelstein, Yang Yang, David P Rosenbaum, Lori Battelli, Glenn M Chertow
Tenapanor improves long-term control of high phosphate concentrations in the blood in patients receiving maintenance dialysis: a plain language summary of the NORMALIZE study. Current medical research and opinion 40 (8) (2024)
Ian Ellis McCoy, Glenn M Chertow
The Use of Kidney Disease Improving Global Outcomes AKI Definitions in AKI Research: PRO. Kidney360 5 (7) (2024)
Arnold Silva, Susan Edelstein, Yang Yang, David P Rosenbaum, Lori Battelli, Glenn M Chertow
Tenapanor improves long-term control of high phosphate concentrations in the blood in patients receiving maintenance dialysis: a plain language summary of the NORMALIZE study. Current medical research and opinion (2024)
Wisanne M Bakker, Ron T Gansevoort, Changyuan Yang, Glenn M Chertow, Hiddo J Lambers Heerspink, Priya Vart
Sodium-Glucose Cotransporter 2 Inhibitors in Older Patients with CKD. Journal of the American Society of Nephrology : JASN (2024)
Margaret K Yu, Priya Vart, Niels Jongs, Ricardo Correa-Rotter, Peter Rossing, John J V McMurray, Fan-Fan Hou, Walter Douthat, Dinesh Khullar, Anna Maria Langkilde, David C Wheeler, Hiddo J L Heerspink, Glenn M Chertow
Effects of Dapagliflozin in Chronic Kidney Disease Across the Spectrum of Age and by Sex. Journal of general internal medicine (2023)
Shuchi Anand, Maria E Montez-Rath, Meri Varkila, Xue Yu, Martha Block, Stephanie Brillhart, Amanda Leppink, Patti Hunsader, Douglas K Owens, Glenn M Chertow, Julie Parsonnet, Geoffrey Block
Feasibility and Acceptability of SARS-CoV-2 Screening among Patients Receiving Hemodialysis: A Pilot Study. Clinical journal of the American Society of Nephrology : CJASN (2023)
Vivek Charu, Jane W Liang, Glenn M Chertow, June Li, Maria E Montez-Rath, Pascal Geldsetzer, Ian H de Boer, Lu Tian, Manjula Kurella Tamura
Heterogeneous Treatment Effects of Intensive Glycemic Control on Kidney Microvascular Outcomes and Mortality in ACCORD. Journal of the American Society of Nephrology : JASN (2023)
Glenn M Chertow, Ricardo Correa-Rotter, Priya Vart, Niels Jongs, John Joseph Valentine McMurray, Ellen Burgess, Anna Maria Langkilde, C David Sjöström, Robert D Toto, David Collins Wheeler, Hiddo J Lambers Heerspink, null null
Effects of Dapagliflozin in Chronic Kidney Disease, With and Without Other Cardiovascular Medications: DAPA-CKD Trial. Journal of the American Heart Association (2023)
Marika M Cusick, Rebecca L Tisdale, Glenn M Chertow, Douglas K Owens, Jeremy D Goldhaber-Fiebert
Population-Wide Screening for Chronic Kidney Disease : A Cost-Effectiveness Analysis. Annals of internal medicine (2023)
Calyani Ganesan, I-Chun Thomas, Maria E Montez-Rath, Glenn M Chertow, John T Leppert, Alan C Pao
Hypocitraturia and Risk of Bone Disease in Patients With Kidney Stone Disease. JBMR plus 7 (9) (2023)
Margaret K Yu, Priya Vart, Niels Jongs, Ricardo Correa-Rotter, Peter Rossing, John J V McMurray, Fan-Fan Hou, Walter Douthat, Dinesh Khullar, Anna Maria Langkilde, David C Wheeler, Hiddo J L Heerspink, Glenn M Chertow
Effects of Dapagliflozin in Chronic Kidney Disease Across the Spectrum of Age and by Sex. Journal of general internal medicine 39 (6) (2023)
Shuchi Anand, Maria E Montez-Rath, Meri Varkila, Xue Yu, Martha Block, Stephanie Brillhart, Amanda Leppink, Patti Hunsader, Douglas K Owens, Glenn M Chertow, Julie Parsonnet, Geoffrey Block
Feasibility and Acceptability of SARS-CoV-2 Screening among Patients Receiving Hemodialysis: A Pilot Study. Clinical journal of the American Society of Nephrology : CJASN (2023)
Cynthia Delgado, Neil R Powe, Glenn M Chertow, Barbara Grimes, Kirsten L Johansen
Muscle Mass and Serum Creatinine Concentration by Race and Ethnicity Among Hemodialysis Patients. Journal of the American Society of Nephrology : JASN (2023)
Glenn M Chertow, Ricardo Correa-Rotter, Priya Vart, Niels Jongs, John Joseph Valentine McMurray, Ellen Burgess, Anna Maria Langkilde, C David Sjöström, Robert D Toto, David Collins Wheeler, Hiddo J Lambers Heerspink, null null
Effects of Dapagliflozin in Chronic Kidney Disease, With and Without Other Cardiovascular Medications: DAPA-CKD Trial. Journal of the American Heart Association 12 (9) (2023)
Carolyn D Seib, Calyani Ganesan, Adam Furst, Alan C Pao, Glenn M Chertow, John T Leppert, Insoo Suh, Maria E Montez-Rath, Alex H S Harris, Amber W Trickey, Electron Kebebew, Manjula Kurella Tamura
Estimated Effect of Parathyroidectomy on Long-Term Kidney Function in Adults With Primary Hyperparathyroidism. Annals of internal medicine (2023)
Benjamin Briggs, Guillermo Garcia-Garcia, Margarita Ibarra-Hernandez, Luz Alcantar-Vallin, Gary Walker, Eric Yu, Aly ElBadry, Brian Fisher, Don Williamson, Glenn M Chertow
Performance characteristics of a prototype dialysate turbidity monitoring system to detect peritonitis in patients receiving peritoneal dialysis. Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis (2023)
Margaret K Yu, Priya Vart, Niels Jongs, Ricardo Correa-Rotter, Peter Rossing, John J V McMurray, Fan-Fan Hou, Walter Douthat, Dinesh Khullar, Anna Maria Langkilde, David C Wheeler, Hiddo J L Heerspink, Glenn M Chertow
Effects of Dapagliflozin in Chronic Kidney Disease Across the Spectrum of Age and by Sex. Journal of general internal medicine 39 (6) (2023)
Glenn M Chertow, Ricardo Correa-Rotter, Priya Vart, Niels Jongs, John Joseph Valentine McMurray, Ellen Burgess, Anna Maria Langkilde, C David Sjöström, Robert D Toto, David Collins Wheeler, Hiddo J Lambers Heerspink, null null
Effects of Dapagliflozin in Chronic Kidney Disease, With and Without Other Cardiovascular Medications: DAPA-CKD Trial. Journal of the American Heart Association 12 (9) (2023)
Meir Schechter, Glenn M Chertow, Hiddo J Lambers Heerspink
Effects of Dapagliflozin on Hospitalizations in Patients With Chronic Kidney Disease. Annals of internal medicine 176 (7) (2023)
Margaret K Yu, Priya Vart, Niels Jongs, Ricardo Correa-Rotter, Peter Rossing, John J V McMurray, Fan-Fan Hou, Walter Douthat, Dinesh Khullar, Anna Maria Langkilde, David C Wheeler, Hiddo J L Heerspink, Glenn M Chertow
Effects of Dapagliflozin in Chronic Kidney Disease Across the Spectrum of Age and by Sex. Journal of general internal medicine 39 (6) (2023)
Vivek Charu, Jane W Liang, Glenn M Chertow, Zhuo Jun Li, Maria E Montez-Rath, Pascal Geldsetzer, Ian H de Boer, Lu Tian, Manjula Kurella Tamura
Heterogeneous treatment effects of intensive glycemic control on kidney microvascular outcomes in ACCORD. medRxiv : the preprint server for health sciences (2023)
Arnold L Silva, Glenn M Chertow, Germán T Hernández, Robert I Lynn, David P Tietjen, David P Rosenbaum, Yang Yang, Susan Edelstein
Tenapanor Improves Long-term Control of Hyperphosphatemia in Patients Receiving Maintenance Dialysis: the NORMALIZE Study. Kidney360 (2023)
Robert A Fletcher, Niels Jongs, Glenn M Chertow, John Joseph Valentine McMurray, Clare Arnott, Meg J Jardine, Kenneth W Mahaffey, Vlado Perkovic, Patrick Rockenschaub, Ellen Burgess, Ricardo Correa-Rotter, Robert D Toto, Muthiah Vaduganathan, David Collins Wheeler, Hiddo J Lambers Heerspink, Brendon L Neuen
Effect of SGLT2 Inhibitors on Discontinuation of Renin-angiotensin System Blockade: A Joint Analysis of the CREDENCE and DAPA-CKD Trials. Journal of the American Society of Nephrology : JASN (2023)
Enass El-Sayed, Youssef M K Farag, Katherine Scovner Ravi, Glenn M Chertow, Finnian R Mc Causland
Association of Bioimpedance Parameters with Increases in Blood Pressure during Hemodialysis. Clinical journal of the American Society of Nephrology : CJASN (2023)
Glenn M Chertow, Ricardo Correa-Rotter, Priya Vart, Niels Jongs, John Joseph Valentine McMurray, Ellen Burgess, Anna Maria Langkilde, C David Sjöström, Robert D Toto, David Collins Wheeler, Hiddo J Lambers Heerspink, null null
Effects of Dapagliflozin in Chronic Kidney Disease, With and Without Other Cardiovascular Medications: DAPA-CKD Trial. Journal of the American Heart Association 12 (9) (2023)
Margaret K Yu, Priya Vart, Niels Jongs, Ricardo Correa-Rotter, Peter Rossing, John J V McMurray, Fan-Fan Hou, Walter Douthat, Dinesh Khullar, Anna Maria Langkilde, David C Wheeler, Hiddo J L Heerspink, Glenn M Chertow
Effects of Dapagliflozin in Chronic Kidney Disease Across the Spectrum of Age and by Sex. Journal of general internal medicine 39 (6) (2023)
Glenn M Chertow, Ricardo Correa-Rotter, Priya Vart, Niels Jongs, John Joseph Valentine McMurray, Ellen Burgess, Anna Maria Langkilde, C David Sjöström, Robert D Toto, David Collins Wheeler, Hiddo J Lambers Heerspink, null null
Effects of Dapagliflozin in Chronic Kidney Disease, With and Without Other Cardiovascular Medications: DAPA-CKD Trial. Journal of the American Heart Association 12 (9) (2023)
Vikram Fielding-Singh, Glenn M Chertow
Clinically Indicated, Equitable Care for Ischemic Heart Disease in CKD: A Call to Action. Journal of the American Society of Nephrology : JASN 34 (4) (2023)
Jinnie J Rhee, Jialin Han, Maria E Montez-Rath, Sun H Kim, Mark R Cullen, Randall S Stafford, Wolfgang C Winkelmayer, Glenn M Chertow
Cardiovascular outcomes associated with prescription of sodium-glucose co-transporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in patients with diabetes and chronic kidney disease. Diabetes, obesity & metabolism 24 (5) (2022)
Priya Vart, Muthiah Vaduganathan, Niels Jongs, Giuseppe Remuzzi, David C Wheeler, Fan Fan Hou, Finnian R Mc Causland, Glenn M Chertow, Hiddo J Lambers Heerspink
Estimated Lifetime Benefit of Combined RAAS and SGLT2 Inhibitor Therapy in Patients with Albuminuric CKD without Diabetes. Clinical journal of the American Society of Nephrology : CJASN (2022)
Pablo Garcia, Jialin Han, Maria E Montez-Rath, Sumi Sun, Tiffany Shang, Julie Parsonnet, Glenn M Chertow, Shuchi Anand, Brigitte Schiller, Graham Abra
SARS-CoV-2 Booster Vaccine Response among Patients Receiving Dialysis. Clinical journal of the American Society of Nephrology : CJASN 17 (7) (2022)
Hiddo J Lambers Heerspink, Glenn M Chertow, Niels Jongs, Ricardo Correa-Rotter, Ellen Burgess, C David Sjöström, Anna Maria Langkilde, David C Wheeler, null null
Effects of Dapagliflozin in People without Diabetes and with Microalbuminuria. Clinical journal of the American Society of Nephrology : CJASN 17 (11) (2022)
Janani Rangaswami, Vivek Bhalla, Glenn M Chertow, Robert A Harrington, Alexander Staruschenko, Katherine R Tuttle, Eugene Braunwald
Changing the Trajectory of Heart Failure and Kidney Disease: A Call for Action. Clinical journal of the American Society of Nephrology : CJASN 17 (5) (2022)
Meir Schechter, Niels Jongs, Glenn M Chertow, Lawrence A Leiter, John Joseph Valentine McMurray, Ricardo Correa-Rotter, Ellen Burgess, Anna Maria Langkilde, C David Sjöström, Robert D Toto, David Collins Wheeler, Hiddo J Lambers Heerspink
Effects of Dapagliflozin on Hospitalizations in Patients With Chronic Kidney Disease : A Post Hoc Analysis of DAPA-CKD. Annals of internal medicine (2022)
Bradley A Warady, Pablo E Pergola, Rajiv Agarwal, Sharon Andreoli, Gerald B Appel, Sripal Bangalore, Geoffrey A Block, Arlene B Chapman, Melanie P Chin, Keisha L Gibson, Angie Goldsberry, Kazumoto Iijima, Lesley A Inker, Clifford E Kashtan, Bertrand Knebelmann, Laura H Mariani, Colin J Meyer, Kandai Nozu, Megan O'Grady, Michelle N Rheault, Arnold L Silva, Peter Stenvinkel, Roser Torra, Glenn M Chertow
Effects of Bardoxolone Methyl in Alport Syndrome. Clinical journal of the American Society of Nephrology : CJASN (2022)
Glenn M Chertow, Priya Vart, Niels Jongs, Anna Maria Langkilde, John Joseph Valentine McMurray, Ricardo Correa-Rotter, Peter Rossing, C David Sjöström, Bergur V Stefansson, Robert D Toto, David C Wheeler, Hiddo J Lambers Heerspink
Quételet (body mass) index and effects of dapagliflozin in chronic kidney disease. Diabetes, obesity & metabolism 24 (5) (2022)
Allen R Nissenson, Glenn M Chertow, Paul T Conway
Breaking the Barriers to Innovation in Kidney Care: The Time is Now. Clinical journal of the American Society of Nephrology : CJASN 17 (4) (2022)
Simke W Waijer, Priya Vart, David Z I Cherney, Glenn M Chertow, Niels Jongs, Anna Maria Langkilde, Johannes F E Mann, Ofri Mosenzon, John Joseph Valentine McMurray, Ellen Burgess, Ricardo Correa-Rotter, Bergur V Stefansson, Robert D Toto, David Collins Wheeler, Hiddo J Lambers Heerspink
Effect of dapagliflozin on kidney and cardiovascular outcomes by baseline KDIGO risk categories: a post hoc analysis of the DAPA-CKD trial. Diabetologia 65 (7) (2022)
Tara I-Hsin Chang, Emily Tamar Tatoian, Maria E Montez-Rath, Glenn M Chertow
Timing of Antihypertensive Medications on Key Outcomes in Hemodialysis: A Cluster Randomized Trial. Kidney360 2 (11) (2021)
Brian M Brady, Bo Zhao, Bich N Dang, Wolfgang C Winkelmayer, Glenn M Chertow, Kevin F Erickson
Patient-Reported Experiences with Dialysis Care and Provider Visit Frequency. Clinical journal of the American Society of Nephrology : CJASN 16 (7) (2021)
Shuchi Anand, Maria E Montez-Rath, Jialin Han, Pablo Garcia, Julie Bozeman, Russell Kerschmann, Paul Beyer, Julie Parsonnet, Glenn M Chertow
Laboratory correlates of SARS-CoV-2 seropositivity in a nationwide sample of patients on dialysis in the U.S. PloS one 16 (4) (2021)
Calyani Ganesan, I-Chun Thomas, Ruth Romero, Shen Song, Simon Conti, Chris Elliott, Glenn M Chertow, Manjula Kurella Tamura, John T Leppert, Alan C Pao
Osteoporosis, Fractures, and Bone Mineral Density Screening in Veterans With Kidney Stone Disease. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 36 (5) (2021)
Xingxing S Cheng, Sai Liu, Jialin Han, Margaret R Stedman, Glenn M Chertow, Jane C Tan, William F Fearon
Trends in Coronary Artery Disease Screening before Kidney Transplantation. Kidney360 3 (3) (2021)
Kate Lyden, Robert Boucher, Guo Wei, Na Zhou, Jesse Christensen, Glenn M Chertow, Tom Greene, Srinivasan Beddhu
Targeting Sedentary Behavior in CKD: A Pilot and Feasibility Randomized Controlled Trial. Clinical journal of the American Society of Nephrology : CJASN 16 (5) (2021)
Aileen X Wang, Stephan Busque, Jamie Kuo, Upinder Singh, Katharina Röeltgen, Benjamin A Pinsky, Glenn M Chertow, John D Scandling, Colin R Lenihan
SARS-CoV-2 Neutralizing Monoclonal Antibodies for the Treatment of COVID-19 in Kidney Transplant Recipients. Kidney360 3 (1) (2021)
Daniel J Watford, Xingxing S Cheng, Jialin Han, Margaret R Stedman, Glenn M Chertow, Jane C Tan
Toward telemedicine-compatible physical functioning assessments in kidney transplant candidates. Clinical transplantation 35 (2) (2020)
Alfred K Cheung, Glenn M Chertow, T Greene, P L Kimmel, M Rahman, D Reboussin, M Rocco, null null
Benefits and risks of intensive blood-pressure lowering in advanced chronic kidney disease. Journal of internal medicine 284 (1) (2018)
Eugene Lin, Glenn M Chertow, Brandon W Yan, Elizabeth Malcolm, Jeremy D Goldhaber-Fiebert
Cost-effectiveness of multidisciplinary care in mild to moderate chronic kidney disease in the United States: A modeling study. PLoS medicine 15 (3) (2018)
Glenn M Chertow, Geoffrey A Block, John F Neylan, Pablo E Pergola, Katrin Uhlig, Steven Fishbane
Safety and efficacy of ferric citrate in patients with nondialysis-dependent chronic kidney disease. PloS one 12 (11) (2017)